Medtronic Cardiovascular

This study tested a new heart valve called Evolut PRO in 638 people with a narrowed or failing aortic valve. The valve was implanted through a tube in the artery, avoiding open-heart surgery. The main goal was to see how many patients survived 30 days after the procedure. The stu…

This study followed over 1000 people who had a procedure to fix a weakened area in the main artery (aortic aneurysm) using a special anchoring device called Heli-FX EndoAnchor. The goal was to see how safe and effective the device is over 5 years. Participants were already gettin…

This study tested a new, less invasive heart valve (CoreValve) in 782 people with severe aortic stenosis who were too high-risk for open-heart surgery. The goal was to see if the valve was safe and effective at improving survival and reducing strokes. The approach uses a catheter…

This study looked at whether a special care plan could improve outcomes for people getting a new heart valve without open-heart surgery (TAVR). Over 1,100 patients with severe aortic stenosis took part. Researchers tracked how well the valve worked and how patients recovered, foc…